The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
出版年份 2018 全文链接
标题
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
作者
关键词
-
出版物
npj Vaccines
Volume 3, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-07-04
DOI
10.1038/s41541-018-0057-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial
- (2017) S.B. Sirima et al. VACCINE
- A Functional Role for Antibodies in Tuberculosis
- (2016) Lenette L. Lu et al. CELL
- Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung
- (2016) J S Woodworth et al. Mucosal Immunology
- Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K
- (2016) Seung Bin Cha et al. VACCINE
- Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool
- (2015) Christopher L. Karp et al. IMMUNOLOGICAL REVIEWS
- Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry
- (2015) Benjamin M. Kagina et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial
- (2015) Hennie Geldenhuys et al. VACCINE
- Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting
- (2015) Adam Penn-Nicholson et al. VACCINE
- Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant
- (2015) Miriam Tendler et al. Frontiers in Immunology
- Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy
- (2014) Eleonora G. Thacher et al. AIDS
- OMIP-022: Comprehensive assessment of antigen-specific human T-cell functionality and memory
- (2014) Andrew J. Graves et al. CYTOMETRY PART A
- Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis
- (2014) S. Bertholet et al. JOURNAL OF IMMUNOLOGY
- Tuberculosis Vaccines and Prevention of Infection
- (2014) Thomas R. Hawn et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- IgG Subclasses and Allotypes: From Structure to Effector Functions
- (2014) Gestur Vidarsson et al. Frontiers in Immunology
- A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults
- (2013) Jaime Montoya et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis
- (2013) Mark T. Orr et al. JOURNAL OF CONTROLLED RELEASE
- Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques
- (2013) S. Jegaskanda et al. JOURNAL OF VIROLOGY
- High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples
- (2012) Eric P. Brown et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The Importance of Adjuvant Formulation in the Development of a Tuberculosis Vaccine
- (2012) S. L. Baldwin et al. JOURNAL OF IMMUNOLOGY
- Therapeutic Immunization against Mycobacterium tuberculosis Is an Effective Adjunct to Antibiotic Treatment
- (2012) Rhea N. Coler et al. JOURNAL OF INFECTIOUS DISEASES
- Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial
- (2012) Isabel Leroux-Roels et al. VACCINE
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis
- (2011) Jaya Chakravarty et al. VACCINE
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
- (2010) Margaret E. Ackerman et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
- (2010) S. Bertholet et al. Science Translational Medicine
- The protective role of antibody responses duringMycobacterium tuberculosisinfection
- (2009) F. Abebe et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- TB vaccines: current status and future perspectives
- (2009) Claus Aagaard et al. IMMUNOLOGY AND CELL BIOLOGY
- Quality and Vaccine Efficacy of CD4+ T Cell Responses Directed to Dominant and Subdominant Epitopes in ESAT-6 from Mycobacterium tuberculosis
- (2009) C. S. Aagaard et al. JOURNAL OF IMMUNOLOGY
- Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
- (2009) T. Lindenstrom et al. JOURNAL OF IMMUNOLOGY
- Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis
- (2009) Iván D. Vélez et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search